1. Patients with heart, liver and kidney dysfunction, hyperkalemia, hypernatremia, metabolic or respiratory alkalosis should be used with caution. 2. Intravenous infusion of compound electrolyte injection may cause excessive liquid and/or solute, resultin

Intravenous infusion. Since the osmotic pressure of this product is higher than 800 mosm/L, it should be infused from the middle vein. The dosage used depends on the amount of amino acid required by the human body. This product is generally recommended to

1.the following patients should be carefully administered(1) patients with myelosuppression; (2) patients with co-infection; (3) patients with heart disease or patients with previous history; (4) patients with liver damage; (5) patients with renal impairm

Among 2,819 intravenous, intravenous, intramuscular clinical studies (including double-blind trials) in 137 in Japan, the clinical outcomes of 1,409 patients who were able to determine efficacy and were approved for this product were as follows (refractor

1. this product can only be used intravenously, can not be administered by other means (the following patients should be used with caution);(1) Patients with preoperative diabetes mellitus and those with arteriosclerosis in the main artery during operatio

At 9 o'clock in the morning, the host officially kicked off the meeting with the poems of“light rain, small lotus, and hyacinth”. The conference has a total of 46 people, including more than 30 people from other provinces, including Northeast, Northwest,…

Finnish time on July 11, 2016 at 09:30 am, Black & Decker Company Oyj and Beijing Huayi Huiyi Medical Devices Co., Ltd. signed a distribution agreement in China on the rapid test of celiac disease. Oddj is a globally operating Finnish biotechnology compan

On July 1st, 2017, the glycerin fructose“re-listing”seminar held by Hainan Melexang Pharmaceutical was successfully held in Beijing. The conference was attended by investment managers and product managers from all over the country. The meeting focused on…